ACTIVE

BASF PHARMA BELGIUM

Financial year 2025 · Closed on 31/12/2025

Net result183,2 k €-45,6 %over 1 year
Equity11,6 M €+1,6 %over 1 year

Identity

Source · BCE/KBO

BASF PHARMA BELGIUM is a Public limited company incorporated in 2012. Its registered office is in Antwerpen.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0845.445.466
Incorporation
23/04/2012
Legal form
Public limited company
Registered office
Scheldelaan 600
2040 Antwerpen · FlandreSee on map
Contributed capital
48 000 000,00 €
Latest accounts
31/12/2025
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflow

Financials

Source · NBB, 14 filings

Trend over 14 financial years

20252024202320222021
Income statement
EBITDA-68,6 k €-75,4 k €-54 k €-50,4 k €-28,5 k €
Operating result-68,6 k €-75,4 k €-54 k €-50,4 k €-28,5 k €
Net result183,2 k €337,1 k €296,4 k €-17,3 k €-28,5 k €
Balance sheet
Equity11,6 M €11,4 M €11,1 M €10,8 M €10,8 M €
Total assets11,6 M €11,5 M €11,1 M €10,8 M €10,8 M €
Debts19,2 k €24,1 k €9,5 k €7,8 k €8,2 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 10 M€ and 25 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 4 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Bart Goossens
Director01/01/2026 → 23/04/2026
Jan Remeysen
Director01/01/2020 → 20/04/2028
Stefanie Demming
Director01/12/2024 → 01/01/2026

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Thorsten Oberreuther
Director01/07/2021 → 2024 accounts
Bernd Brian
Director18/04/2019 → 01/07/2021

Other companies at this address

Scheldelaan 600 2040 Antwerpen
CompanyCBE no.
BASF Antwerpen● Active
0404.754.472
0862.390.376
0879.406.156
0448.501.769
0419.018.620
0448.496.920
0448.496.821
0837.473.452
0842.037.204
0806.439.291
ZANDVLIET POWER● Active
0477.543.470

Full financial information

Source · NBB
202520242023202220212020
Type of accountFull modelFull modelFull modelFull modelFull modelFull model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date28/05/202605/05/202513/05/202404/05/202302/06/202226/04/2021
General meeting23/04/202617/04/202518/04/202420/04/202321/04/202222/04/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 14 filings
ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202523/04/202628/05/2026DutchPDF
Full model31/12/202417/04/202505/05/2025DutchPDF
Full model31/12/202318/04/202413/05/2024DutchPDF
Full model31/12/202220/04/202304/05/2023DutchPDF
Full model31/12/202121/04/202202/06/2022DutchPDF
Full model31/12/202022/04/202126/04/2021DutchPDF
Full model31/12/201923/04/202013/10/2020DutchPDF
Full model31/12/201818/04/201917/05/2019DutchPDF
Full model31/12/201719/04/201816/05/2018DutchPDF
Full model31/12/201620/04/201730/05/2017DutchPDF
Full model31/12/201521/04/201619/05/2016DutchPDF
Full model31/12/201423/04/201501/06/2015DutchPDF
Full model31/12/201317/04/201415/05/2014DutchPDF
Full model31/12/201218/04/201317/05/2013DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 10 M€ and 25 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 4 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Bart Goossens
Director01/01/2026 → 23/04/2026
Jan Remeysen
Director01/01/2020 → 20/04/2028
Stefanie Demming
Director01/12/2024 → 01/01/2026

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Thorsten Oberreuther
Director01/07/2021 → 2024 accounts
Bernd Brian
Director18/04/2019 → 01/07/2021

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates09/06/2026
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates02/02/2026
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates19/05/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates24/02/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates12/06/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other11/05/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Mandates20/05/2022
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates03/08/2021
    ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Incorporation
Name
Registered office
Annual accounts
Filings14 filings
Mandates
Bart Goossens
Stefanie Demming
Jan Remeysen
Thorsten Oberreuther
Bernd Brian
Wouter DE GEEST
Jürgen BARWICH
20122013201420152016201720182019202020212022202320242025202620272028
BASF PHARMA BELGIUM
Scheldelaan 600, 2040 Antwerp-2040
Director
Director
Director
Director
Director
Director
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Scheldelaan 600, 2040 Antwerp-2040Current
accounts 2021 → 2025
Accounts 2025 · 2026-00136598

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
BASF PHARMA BELGIUMCurrent
accounts 2021 → 2025
Accounts 2025 · 2026-00136598

Events

  1. 01/01/2026
    nominationBart Goossens · bestuurder
  2. 2025
    Annual accounts 2025183,2 k €↓
  3. 08/12/2025
    nominationBart Goossens · bestuurder
  4. 2024
    Annual accounts 2024337,1 k €↑
  5. 01/12/2024
    nominationStefanie Demming · bestuurder
  6. 18/04/2024
    nominationDeloitte Bedrijfsrevisoren BV · commissaris
  7. 2023
    Annual accounts 2023296,4 k €↑
  8. 2022
    Annual accounts 2022-17,3 k €↑
  9. 21/04/2022
    reconductionJan Remeysen · bestuurder
  10. 21/04/2022
    reconductionThorsten Oberreuther · bestuurder
  11. 2021
    Annual accounts 2021-28,5 k €↓
  12. 2020
    Annual accounts 2020-26,9 k €↑
  13. 2019
    Annual accounts 2019-28,6 k €↑
  14. 2018
    Annual accounts 2018-35 M €↓
  15. 2017
    Annual accounts 2017-70,4 k €↓
  16. 2016
    Annual accounts 2016-37,9 k €↑
  17. 2015
    Annual accounts 2015-570,6 k €↓
  18. 2014
    Annual accounts 2014-395,2 k €↑
  19. 2013
    Annual accounts 2013-592 k €↓
  20. 2012
    Annual accounts 2012-410,1 k €
  21. 23/04/2012
    IncorporationPublic limited company